Verona pharma announces august 2021 virtual investor conference participation

London and raleigh, n.c., july 27, 2021 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that david zaccardelli, pharm. d., president and chief executive officer, will present at the following virtual investor conferences in august 2021:
VRNA Ratings Summary
VRNA Quant Ranking